Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2016-10-14 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于非公开发行股票申请文件二次反馈意见回复的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding its response to a regulatory authority's (China Securities Regulatory Commission) second feedback on a non-public stock issuance application. It mentions the submission of reply documents and the ongoing approval process, highlighting uncertainty about approval. The document is short (790 characters) and serves as an update on the regulatory review process rather than containing financial statements or detailed financial data. It is not a full report but an announcement related to capital raising activities. Therefore, it fits best under Capital/Financing Update (CAP).
2016-10-14 Chinese
关于召开2016年第二次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2016 second extraordinary general meeting of shareholders for the company. It includes information about the meeting time, voting methods (on-site and online), agenda items to be discussed and voted on, registration procedures, and voting instructions. The document also contains attachments such as the voting process and proxy authorization form. There is no financial data or results reported, nor is it a transcript or presentation. It is clearly an announcement related to a shareholders' meeting, specifically an Extraordinary General Meeting (EGM). The content focuses on informing shareholders about the meeting logistics and agenda, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since this document is a notice about the meeting and voting procedures rather than the solicitation of proxies or the actual voting results, it aligns best with Proxy Solicitation & Information Statement (PSI). The document length (7320 characters) and detailed procedural content support this classification rather than a brief announcement or a report publication announcement.
2016-10-12 Chinese
非公开发行A股股票预案（第三次修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled as a "非公开发行 A 股股票预案 (第三次修订稿)" which translates to "Non-public issuance of A shares stock plan (third revision)". It contains detailed information about a non-public offering of shares, including issuance background, purpose, pricing, subscription contracts, use of proceeds, and related approvals. The document is a comprehensive plan or proposal for a capital raising event through a non-public share issuance. It is not a simple announcement but a detailed plan document. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document length is substantial (15,000 characters), indicating it is not a brief announcement or a report publication announcement. There is no indication that this is an annual report, earnings release, or other report types. Therefore, the most appropriate classification is CAP with high confidence.
2016-09-26 Chinese
非公开发行A股股票募集资金运用的可行性分析报告（第二次修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled as a "Feasibility Analysis Report on the Use of Funds Raised from Non-public Issuance of A Shares" by Qidi Guhan Group Co., Ltd. It details the planned use of funds raised through a non-public stock issuance, including investment projects, their costs, expected benefits, and impacts on the company's financial and operational status. The content focuses on capital raising and the allocation of those funds to specific projects, which aligns with a capital/financing update rather than a full financial report or earnings release. There is no indication that this is an annual or interim report, audit report, or earnings release. The document is comprehensive and over 7,000 characters, so it is not a mere announcement of a report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2016-09-26 Chinese
关于调整公司非公开发行股票方案及与认购对象签署附条件生效的股份认购合同之补充合同（二）涉及关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the adjustment of a non-public stock issuance plan and the signing of supplementary contracts related to the stock subscription, involving related party transactions. It details the parties involved, the number of shares, pricing, board approvals, and regulatory compliance. The content focuses on capital raising activities through a non-public issuance of shares, including pricing and shareholder approvals. There are no financial statements or quarterly/yearly financial results presented, nor is it a transcript or a report of voting results. The document is a formal announcement about financing activities and related party transactions, which fits the category of Capital/Financing Update (CAP). The document length is about 4500 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the appropriate classification is CAP with high confidence.
2016-09-26 Chinese
关于与非公开发行股票认购对象签署附条件生效的股份认购合同之补充合同（二）及终止合同的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of supplementary and termination contracts related to a non-public stock issuance subscription agreement. It details the parties involved, subscription amounts, and contract terms. The content focuses on changes and updates to financing agreements rather than presenting financial statements or results. There is no indication of financial performance data, audit information, or management discussion. The document is a formal announcement about capital raising activities and contract modifications related to share issuance. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (5550 characters) and detailed contractual information support this classification with high confidence.
2016-09-26 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.